drugset / Trial / NCT00106587

Treatment of In-Stent Restenosis by Paclitaxel Coated PTCA Balloons (PACCOCATH - ISR I)

NCT00106587 ↗

Phase 1/2 Completed 52 enrolled University Hospital, Saarland
RandomizedParallel-groupSingle-blindTreatment

Summary

The PACCOCATH ISR study is a randomized, double-blinded German multicenter trial on the efficacy and tolerance of a paclitaxel coated balloon catheter in coronary in-stent restenosis.

Timeline

Start
2003-12
Primary completion
2006-11
Completion
2012-03

Outcome

Met primary endpoint

paper in-segment late luminal loss was 0.74+/-0.86 mm in the uncoated-balloon group versus 0.03+/-0.48 mm in the coated-balloon group (P=0.002). PMID 17101615 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Paclitaxel Small molecule 3 ug/m2 —

Indications